(0.07%) 5 521.00 points
(0.14%) 39 898 points
(0.15%) 19 780 points
(-0.06%) $81.58
(0.68%) $2.83
(-0.27%) $2 338.00
(0.08%) $29.55
(0.49%) $1 006.70
(0.04%) $0.932
(-0.05%) $10.53
(0.02%) $0.788
(-0.84%) $87.25
0.00% $ 29.06
Live Chart Being Loaded With Signals
CinCor Pharma, Inc., a clinical-stage biopharmaceutical company, engages in the development of treatments for cardio-renal diseases. It is involved in developing CIN-107, which is in Phase II clinical trial for the treatment of hypertension, primary aldosteronism, and other cardio-renal diseases, as well as in Phase I clinical trial to treat chronic kidney diseases...
Stats | |
---|---|
Dzisiejszy wolumen | 0 |
Średni wolumen | 625 748 |
Kapitalizacja rynkowa | 1.27B |
EPS | $-0.480 ( Q3 | 2022-11-03 ) |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E |
-14.46 (Sector) 42.63 (Industry) 24.32 |
ATR14 | $0.860 (2.96%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2023-02-24 | 5am Partners Vi, Llc | Sell | 496 323 | Common Stock |
2023-02-24 | Healy James | Sell | 9 803 | Common Stock |
2022-11-28 | Healy James | Sell | 6 000 | Common Stock |
2023-02-24 | Healy James | Sell | 19 608 | Common Stock |
2023-02-24 | Healy James | Sell | 6 073 949 | Common Stock |
INSIDER POWER |
---|
-75.83 |
Last 98 transactions |
Buy: 39 839 974 | Sell: 98 795 779 |
Wolumen Korelacja
CinCor Pharma, Inc. Korelacja
10 Najbardziej pozytywne korelacje |
---|
10 Najbardziej negatywne korelacje |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
CinCor Pharma, Inc. Korelacja - Waluta/Towar
CinCor Pharma, Inc. Finanse
Annual | 2021 |
Przychody: | $0.00 |
Zysk brutto: | $0.00 (0.00 %) |
EPS: | $-1 422.09 |
FY | 2021 |
Przychody: | $0.00 |
Zysk brutto: | $0.00 (0.00 %) |
EPS: | $-1 422.09 |
FY | 2020 |
Przychody: | $0.00 |
Zysk brutto: | $0.00 (0.00 %) |
EPS: | $-0.950 |
FY | 2019 |
Przychody: | $0.00 |
Zysk brutto: | $0.00 (0.00 %) |
EPS: | $-0.214 |
Financial Reports:
No articles found.
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
CinCor Pharma, Inc.
CinCor Pharma, Inc., a clinical-stage biopharmaceutical company, engages in the development of treatments for cardio-renal diseases. It is involved in developing CIN-107, which is in Phase II clinical trial for the treatment of hypertension, primary aldosteronism, and other cardio-renal diseases, as well as in Phase I clinical trial to treat chronic kidney diseases. CinCor Pharma, Inc. has a license agreement with F. Hoffman-La Roche Ltd. and Hoffmann-La Roche Inc. The company was incorporated in 2018 and is headquartered in Boston, Massachusetts.
O Sygnały na żywo
Prezentowane na tej stronie sygnały na żywo pomagają określić, kiedy KUPIĆ lub SPRZEDAĆ BRAK DANYCH. Sygnały mogą mieć opóźnienie wynoszące nawet 1 minutę; jak wszystkie sygnały rynkowe, istnieje ryzyko błędu lub pomyłki.
Sygnały transakcyjne na żywo nie są ostateczne i getagraph.com nie ponosi odpowiedzialności za żadne działania podjęte na podstawie tych sygnałów, jak opisano w Warunkach Użytkowania. Sygnały opierają się na szerokim zakresie wskaźników analizy technicznej